Form 8-K - Current report:
SEC Accession No. 0001104659-18-030309
Filing Date
2018-05-03
Accepted
2018-05-03 16:53:32
Documents
3
Period of Report
2018-04-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-12707_18k.htm 8-K 39037
2 EX-99.1 a18-12707_1ex99d1.htm EX-99.1 90302
3 GRAPHIC g127071mm01i001.jpg GRAPHIC 2093
  Complete submission text file 0001104659-18-030309.txt   133823
Mailing Address 9 FOURTH AVE WALTHAM MA 02451
Business Address 9 FOURTH AVE WALTHAM MA 02451 617-500-2802
OvaScience, Inc. (Filer) CIK: 0001544227 (see all company filings)

EIN.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35890 | Film No.: 18804635
SIC: 2834 Pharmaceutical Preparations